Download - Bayer HealthCare

Bayer HealthCare’s Medical Care Division is comprised of two business units – radiology
& interventional and Diabetes Care. The radiology & interventional unit was formed in 2012
through the combination of Bayer HealthCare’s contrast agent and medical devices
businesses.
radiology & interventional is a global leader in developing and manufacturing contrast
agents used in X-ray, computed tomography (CT) and magnetic resonance imaging
(MRI), as well as injection systems for diagnostic and therapeutic medical proce-
dures in CT, MRI and cardiovascular and peripheral vascular disease. The unit also
provides service support for the systems as well as medical data management
products.
Products include the contrast agents Ultravist, Magnevist and Gadovist/Gadavist;
the injection systems Stellant D and Spectris Solaris EP; the thrombectomy system
AngioJet Ultra; the atherectomy system JetStream; and the Certegra Informatics
Platform.
The products are provided to cardiologists, radiologists and vascular surgeons in
hospitals and out-patient clinical sites through a global direct sales organization,
supplemented in some locations by local distributors.
The Diabetes Care unit is one of the leading providers of blood glucose monitoring
systems, monitors to test glycated hemoglobin (HbA1c), lancing devices and diabetes
management software.
The portfolio of blood glucose meters includes Contour, Contour XT, Contour Next EZ,
Contour Link* and Contour Next Link* (*International alliance with Medtronic, Inc. to
develop innovative next generation diabetes management solutions for patients
worldwide), Contour USB, Contour Next USB, Contour TS and Breeze 2.
Monitors for measurement of glycated hemoglobin include the A1CNow+ monitor for
health care providers and A1CNow Selfcheck for home use.
Outside Europe, these products are generally sold to consumers through pharmacies,
drugstores, mass merchants, hospitals or wholesalers. In Europe, they are sold mainly
through pharmacies.
MEDiCAl CArE DIVISIOn
11